Back to Market Feed

RASUVO 17.5 MG/0.35 ML AUTOINJ

$409.9290per ML

High Outlier

Strength

17.5 mg/.35mL

Manufacturer

Medexus Pharma Inc.

NDC

59137052504

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/1/2026

Active Ingredients

METHOTREXATE SODIUM

Approval Type

New Drug (NDA)

FDA Application

On Market Since

7/10/2014

Pharmacological Classes

Folate Analog Metabolic Inhibitor

Folic Acid Metabolism Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

+2.6%

6M

+2.1%

1Y

+2.1%

3Y

N/A

5Y

N/A

All

+5.2%

Generic Alternatives

1 alternative • Same active ingredient

OTREXUP 17.5 MG/0.4 ML AUTOINJ

54436001704•Antares Pharma, Inc.

Related Drugs

Same classification

XATMEP 2.5 MG/ML ORAL SOLUTION

52652200106•Azurity Pharmaceuticals Inc.